Improved Outcomes With Early Mitral Regurgitation Surgery

This article originally appeared here.
Mitral Regurgitation Surgery
Mitral Regurgitation Surgery

(HealthDay News) — Excess postoperative mortality and morbidity is seen with use of guideline-based indications for mitral regurgitation surgery vs. early surgery, according to a study published in the July issue of the Journal of Thoracic and Cardiovascular Surgery.

Maurice Enriquez-Sarano, MD, from the Mayo Clinic in Rochester, MN, and colleagues examined outcomes for 1,512 patients undergoing surgical correction of pure organic mitral regurgitation. Patients were stratified into class I triggers (heart failure symptoms, ejection fraction <60%, end-systolic diameter ≥40mm [ClassI-T]; 794 patients), class II triggers based on clinical complications (atrial fibrillation or pulmonary hypertension [ClassII-CompT]; 195 patients), and early class II triggers based on a combination of severe mitral regurgitation and high probability of valve repair (ClassII-EarlyT; 523 patients).

The researchers identified the highest operative mortality with ClassI-T (1.1 vs. 0 and 0%; P=0.016). Compared with ClassII-EarlyT, lower long-term survival was seen for ClassI-T and ClassII-CompT (adjusted hazard ratios, 1.89 and 1.39, respectively). Age stratification, inverse probability weighting, and expected survival adjustment confirmed the postoperative excess mortality with ClassI-T and ClassII-CompT. ClassI-T and ClassII-CompT had high excess postoperative failure (adjusted hazard ratios, 2.49 and 1.98, respectively).

"The type of guideline-based indication for surgical correction of organic mitral regurgitation is associated with profound outcome consequences on long-term postoperative mortality and heart failure, despite low operative risk and high repair rates," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Loading links....